- Home
- » Tags
- » Lifastuzumab vedotin
Top View
- The Dolaflexin-Based Antibody-Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/Napi2b
- (2006.01) C07d 413/14
- Cutaneous Toxicity Associated with Enfortumab Vedotin Treatment of Metastatic Urothelial Carcinoma
- IMSN Open Letter on Antibody-Drug Conjugate 2151012
- Oncology Drugs in the Pipeline
- Patient Selection Strategies to Maximize Therapeutic Index Of
- The First Annual Miami General Medical Oncology Symposium
- Gm, Ke, Lr, Ls, Mw, Mz, Na, Rw, Sd, Sl, St, Sz, Tz, Ug, Zm, Zw
- "The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
- QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
- Internationales 2018 Publications
- (INN) for Biological and Biotechnological Substances
- Úvod Do Chemie Léčiv 10 Protinádorová Léčiva
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
- Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
- Current Status of Marine-Derived Compounds As Warheads in Anti-Tumor Drug Candidates
- Antibody-Drug Conjugates: a Promising Novel Therapy for the Treatment of Ovarian Cancer
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri